Current Issue January 2012, Vol. 30, No. 1

In This Issue

Prostate-specific antigen (PSA) should drive doing prostate biopsies
January 2012 (Vol. 30 | No. 1 | Pages 1-2)
Stacy Loeb, William J. Catalona
- Full Text
- PDF (104 KB)
The multi-disciplinary management of high-risk prostate cancer
January 2012 (Vol. 30 | No. 1 | Pages 3-15)
Jonathan C. Picard, Ali-Reza Golshayan, David T. Marshall, Krisha J. Opfermann, Thomas E. Keane
GREB1 tissue expression is associated with organ-confined prostate cancer
January 2012 (Vol. 30 | No. 1 | Pages 16-20)
Alberto A. Antunes, Kátia R. Leite, Sabrina T. Reis, Juliana M. Sousa-Canavez, Luiz H. Camara-Lopes, Marcos F. Dall'Oglio, Miguel Srougi

Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study
27 January 2012
Alessandro Antonelli, Nicola Arrighi, Serena Corti, Tiziano Zanotelli, Alberto Cozzoli, Sergio Cosciani Cunico, Claudio Simeone
Abstract: Objectives: Type-2 diabetes mellitus (DM) is a metabolic disease affecting several million people all over the world. The correlation between DM and malignancies is well established due to t...
Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes
27 January 2012
Shiekh Tanveer Ahmad, Wani Arjumand, Amlesh Seth, Sana Nafees, Summya Rashid, Nemat Ali, Oday O. Hamiza, Sarwat Sultana
Abstract: The progressive increase in sporadic renal cell carcinoma (RCC) observed in industrialized countries supports the opinion that certain carcinogens present in the environment (tobacco smoke, ...
Patterns of autophagy in urothelial cell carcinomas—the significance of “stone-like” structures (SLS) in transurethral resection biopsies
27 January 2012
Efthimios Sivridis, Michael I. Koukourakis, Savvas E. Mendrinos, Stavros Touloupidis, Alexandra Giatromanolaki
Abstract: 0bjectives: To investigate the microtubule-associated protein LC3A, presumed to reflect autophagic activity, in urothelial cell carcinomas (UCC) for its relevance with muscle invasion in tra...
The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor
24 January 2012
Zilian Cui, Shancheng Ren, Ji Lu, Fubo Wang, Weidong Xu, Yi Sun, Min Wei, Junyi Chen, Xu Gao, Chuanliang Xu, Jian-Hua Mao, Yinghao Sun
Abstract: Objective: Emerging evidences implicate long noncoding RNAs (lncRNAs) are deregulated in cancer development. The purpose of the current study is to investigate the role of new lncRNA, named ...
Adjuvant and neoadjuvant therapy for renal cell carcinoma: A survey of the Society of Urologic Oncology
24 January 2012
Conrad M. Tobert, Robert G. Uzzo, Christopher G. Wood, Brian R. Lane
Abstract: Objective: Several systemic agents have been approved for patients with advanced renal cell carcinoma (RCC) and others are in various stages of development. We surveyed members of the Societ...

View More Articles in Press...

On the Cover

New Issue Alert

Free Trial Issue

Journal Ranking

2010 Impact Factor: 3.172

Ranks 15th of 69 journals in the Urology & Nephrology category.

© 2011 Journal Citation Reports®, Thomson Reuters

Journal Access

Full-text articles are available from 1995 to the present. (The numbering gap between Volumes 7 and 21 results from a title merger.) Access to abstracts is complimentary. Access to full text is limited to Society of Urologic Oncology members as well as personal subscribers.

Activate Online Access

Publishing Information

Urologic Oncology: Seminars and Original Investigations is published by Elsevier for the Society of Urologic Oncology (SUO).

Access this journal onSciVerse ScienceDirect

Seminar Section

Impact of poverty and race/ethnicity on treatment and management of urologic cancers

KATHERINE S. VIRGO, PH.D., M.B.A., GUEST EDITOR

Impact of poverty and race/ethnicity on treatment and management of urologic cancers Free

About SUO

The Society of Urologic Oncology (SUO) was created in 1984 to enable qualified members primarily interested in the care of patients with malignant genitourinary diseases to meet for the purpose of discussion, development, and implementation of ideas to improve care. The Society and its bylaws conform to the guidelines and bylaws of the American Urological Association (AUA).

About Urologic Oncology: Seminars and Original Investigations

Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. This new journal combines the original research from Urologic Oncology: Seminars and Original Investigations with the comprehensive single topic overviews from Seminars in Urologic Oncology. The combined publication delivers timely clinical research and up-to-date comprehensive reviews of critical scientific relevance. Each issue comprises original articles and reviews including an in-depth Seminar examining a specific clinical dilemma. All articles are of significant interest to all clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.